Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs.
about
P-TEFb goes viralIdentification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screenCD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21Cyclin-dependent kinase activity controls the onset of the HCMV lytic cyclePurvalanol A, olomoucine II and roscovitine inhibit ABCB1 transporter and synergistically potentiate cytotoxic effects of daunorubicin in vitroDrug discovery and the use of computational approaches for infectious diseases.Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants.Inhibition of Eimeria tenella CDK-related kinase 2: From target identification to lead compounds.Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers.CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.Emerging drugs for varicella-zoster virus infections.Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses.Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy.Exploring kinase inhibitors as therapies for human arenavirus infections.The Emerging Roles of Viroporins in ER Stress Response and Autophagy Induction during Virus InfectionCyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity.Molecular targets for antiviral therapy of cytomegalovirus infections.6-desfluoroquinolones as HIV-1 Tat-mediated transcription inhibitors.Cellular kinases incorporated into HIV-1 particles: passive or active passengers?Potential of protein kinase inhibitors for treating herpesvirus-associated disease.The cyclin-dependent kinase ortholog pUL97 of human cytomegalovirus interacts with cyclinsNegative regulation of type I IFN signaling by phosphorylation of STAT2 on T387.P-TEFb goes viral.The Interaction between Cyclin B1 and Cytomegalovirus Protein Kinase pUL97 is Determined by an Active Kinase DomainInhibition of the cyclin-dependent kinases at the beginning of human cytomegalovirus infection specifically alters the levels and localization of the RNA polymerase II carboxyl-terminal domain kinases cdk9 and cdk7 at the viral transcriptosome.High-throughput screening with the Eimeria tenella CDC2-related kinase2/cyclin complex EtCRK2/EtCYC3a.The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties.Upstream regulators of the Hippo pathway.Elite control of HIV: p21 (waf-1/cip-1) at its best.Aldol-type compounds from water-soluble indole-3,4-diones: synthesis, kinetics, and antiviral properties.Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs.
P2860
Q26741360-DF8E6F1B-CC2C-463B-B819-ADB6DE9A22BCQ26747306-F1F32F6E-008E-4395-A4B1-CEAF32B1EBF2Q28307312-4C809A80-FB25-451E-8353-38CF6A2D40ABQ28475459-E2D3EA51-AD2F-4B7D-8E88-776397C17538Q28537944-EFFF96A6-0E79-4A40-B49C-5D8D576A88D6Q30404272-4764DCB7-D338-415B-83FE-A4DECE9FA989Q33458341-CC71B0E3-1937-49C5-B520-35E2D274338AQ33614977-C3C711BF-A10D-44AA-86BB-799FBC9578F8Q33815957-D7FF61B9-3476-4706-9D5E-FAC9121DDF8FQ33944230-FA1F7C01-932E-46D7-B746-0B5C7F60A5E7Q34027426-2DF08409-28E5-4DAE-A904-1B8DE6DD5999Q34182763-83F8C53F-0ECF-4D43-BA80-88685635250FQ35106892-2E5116E2-B17B-4505-8F19-BDD365118219Q35635901-E9308989-A70C-4246-BDF8-0F40D049003FQ35808638-B55DF17C-DC1F-4CC6-9E99-84999D496FE7Q37136798-0E80889C-53B7-45AF-93D7-B9C357FA221FQ37573779-02E5C0EC-2188-4A72-AAC9-4C3247C3848EQ37855902-064DCF69-7C70-4044-A276-177CDC1DC530Q37925860-CC43437A-ADAF-4767-A75E-0AB1AB5DBB0BQ38100859-50CB77E0-7D21-49C7-B6EF-C1B0CF8D81E3Q38534801-F42C55C2-D062-457C-B029-C99B80BEE185Q38730820-115B3701-E627-4F28-AE4A-4D7A26969223Q38896947-4F02F316-64FC-4865-9211-F27844631E5BQ41485874-CAA4D5F6-CDC3-4BEC-A317-E2C19207BC82Q41770253-5052ACFB-A488-48A4-9D26-97A0C57C3A73Q42112474-5A1811C9-B621-4EBD-8A40-3DD6E7771E07Q42122796-40CD768E-4448-488E-B6BB-AD98B5CFBF60Q42414224-54CBA8C8-1944-4A78-AB6F-404E94303FD0Q43120030-5D8BCD31-8942-4FDE-9A1A-F8EAD7EE54F1Q43863289-6D309B51-6482-4415-90F6-C79EE025EED9Q46916610-F2191D42-1202-44C5-803D-E6FF9749653A
P2860
Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Five years of progress on cycl ...... l targets for antiviral drugs.
@ast
Five years of progress on cycl ...... l targets for antiviral drugs.
@en
type
label
Five years of progress on cycl ...... l targets for antiviral drugs.
@ast
Five years of progress on cycl ...... l targets for antiviral drugs.
@en
prefLabel
Five years of progress on cycl ...... l targets for antiviral drugs.
@ast
Five years of progress on cycl ...... l targets for antiviral drugs.
@en
P2093
P2860
P1476
Five years of progress on cycl ...... l targets for antiviral drugs.
@en
P2093
Jonathan J Lacasse
Luis M Schang
Mireille R St Vincent
P2860
P304
P356
10.1177/095632020601700601
P577
2006-01-01T00:00:00Z